Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformai radiotherapy in patients with gynecologic malignancies

European Journal of Gynaecological Oncology

Volumn 30, Issue 5, 2009, Pages 547-551

  Igdem S ^a   Ercan, T ^b   Alco G ^b   Zengin, F ^b   Ozgules R ^b   Geceer, G ^b   Okkan, S ^a   Ober A ^b   Turkan, S ^b  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b Florence Nightingale Gayrettepe Hospital   (Turkey)

Author keywords

Gynecologic malignancies; Organ sparing; Pelvic IMRT

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TARGET VOLUME; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PARAMETER; PLANNING TARGET VOLUME; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RADIOMETRY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 70350048602     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bandy L.C., Clarke-Pearson D.L., Soper J.T., Mutch D.G., MacMillan J., Creasman W.T.: "Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation". Gynecol. Oncol., 1987, 26, 160.
2. Barter J.F., Soong S.J., Shingleton H.M., Hatch K.D., Orr J.W. Jr.: "Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer". Gynecol. Oncol., 1989, 32, 292.
3. Green J.A., Kirwan J.M., Tierney J.F., Symonds P., Fresco L., Collingwood M. et al.: "Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and metaanalysis". Lancet, 2001, 358, 781. (Pubitemid 32868726)
4. Roeske J.C., Lujan A., Rotmensch J., Waggoner S.E., Yamada D., Mundt A.J.: "Intensity modulated pelvic radiation in patients with gynecologic malignancies". Int. J. Radial. Oncol. Biol. Phys., 2000, 48, 1613. (Pubitemid 30838394)
5. Portelance L., Chao K.S.C., Grigsby P.W., Bennet H., Low D.: "Intensity modulated radiation therapy reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and paraaortic irradiation". Int. J. Radiat. Oncol. Biol., Phys., 2001, 51, 261. (Pubitemid 32758886)
6. Roeske J.C., Bonta D., Mell L.K., Lujan A.E., Mundt A.J.: "A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity modulated whole pelvic radiation therapy". Radiother. Oncol., 2003, 69, 201. (Pubitemid 37485881)
7. Chen M.F., Tseng C.J., Tseng C.C., Kuo Y.C., Yu C.Y., Chen W.C.: "Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiotherapy: Comparison with conventional radiotherapy". Int. J. Radiat. Oncol. Biol. Phys., 2007, 67, 1438.
8. Mell L.K., Kochanski J.D., Roeske J.C., Haisam J.J., Mehta N., Yamada S.D. et al.: "Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiotherapy". Int. J. Radiat. Oncol. Biol. Phys., 2006, 66, 1356. (Pubitemid 44778931)
9. International Comission on Radiation Units and Measurements (ICRU) Report Number 50. Prescribing, recording, and reporting photon beam therapy. Washington, DC, ICRU, 1993.
10. Guidelines fort the delineation of the CTV in postoperative pelvic RT. www.rtog.org/gynatlas/main.html.
11. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P. et al.: "Randomised study of radical surgery versus radiotherapy for Stage Ib-IIa cervical cancer". Lancet, 1997, 350, 535. (Pubitemid 27348428)
12. Peters W.A., Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S. et al.: "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix". J. Clin. Oncol., 2000, 18, 1606.
13. Grigsby P.W.: "Update on radiation therapy for endometrial cancer". Oncology (Huntingt), 2002, 16, 777.
14. D'Souza W.D., Ahamad A., Iyer R., Salehpour M.R., Jhingran A., Eifel P.J.: "Feasibility of dose escalation using IMRT in posthysterectomy cervical carcinoma". Int. J. Radiat. Oncol. Biol. Phys., 2005, 61, 1062. (Pubitemid 40340900)
15. Roeske J.C., Lujan A., Reba R.C., Penney B.C., Yamada S.D., Mundt A.J.: "Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies". Radiother. Oncol., 2005, 77, 11. (Pubitemid 41503383)
16. Ellis R.E.: "The distribution of active bone marrow in the adult". Phys. Med. Biol., 1961, 5, 255.
17. Ahamad A., D'Souza W., Salehpour M., Iyer R., Tucker S.L., Jhingran A. et al.: "Intensity Modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal tissue sparing effect to margin size". Int. J. Radiat. Oncol. Biol. Phys., 2005, 62, 1117.
18. Georg P., Georg D., Hillbrand M., Kirisits C., Pötter R.: "Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies". Radiother. Oncol., 2006, 80, 19. (Pubitemid 44205303)